U.S. Infection Control Market

U.S. Infection Control Market Size

The U.S. infection control market was valued at USD 21.79 billion in 2025. The market is estimated at USD 22.99 billion in 2026 and is projected to reach USD 35.28 billion by 2034, growing at a CAGR of 5.5% from 2026 to 2034.

An increasing number of surgical procedures is one of the major factors promoting the infection control market in the U.S. Some of the most common surgical procedures in the U.S. are carotid endarterectomy, cesarean section, coronary artery bypass, and low back pain surgery. During surgeries, there is a high possibility for infection spread due to the medical devices and the equipment used. In addition, the equipment used for one person should not be used for another person without proper sterilization. If did, that may increase infection in the other person. To avoid such situations, infection control plays a significant role in preventing infection spread to the patient or the health care provider.

Growing awareness around the prevention and control of infection and an increasing number of programs on infection control further propel the infection control market in the U.S. The U.S. government has started several programs to prevent infection spread in healthcare settings. In addition, they give demos of infection control usage benefits in the healthcare setting, which also fast increases patient recovery. However, the government has been strict about following rules for the prevention and control of infection in recent years due to the increase in pandemics in many regions.

Technical advancements in sterilization equipment are also accelerating the growth rate of the infection control market. For example, most U.S. hospitals use sensor-based equipment to clean the surrounding by detecting viruses in certain places, such as patient rooms and operation theatres. As a result, Manu manufacturers are focused on designing products that are handy to remove the infection or to prevent the surrounding from the infection, which helps in not spreading of infection to the surrounding people.

However, the side effects of using a chemical disinfectant are highly concentrated disinfectants that worsen the situation and hamper the market growth. In addition, the lack of awareness of how to use these infection control products and equipment is further inhibiting the growth rate of the infection control market in the U.S.

This research report on the U.S. infection control market has been segmented and sub-segmented into the following categories.

U.S. Infection Control Market Analysis By Products and Services

• Cleaning and disinfection products
• Sterilization products and services
• Endoscope reprocessing products
• Protective equipment
• Others

U.S. Infection Control Market Analysis By End-User

• Hospitals and clinics
• Medical device companies
• Pharmaceutical companies
• Life sciences companies
• Food Industry
• Others

U.S. Infection Control Market Analysis By Country

• The United States

Geographically, the U.S. accounted for the leading share of the global market in 2024. The growing older population and an increasing number of chronic diseases favor the market growth in the United States. Nearly 20 percent of people in the U.S. are aged above 60. In the U.S., healthcare delivery is essential for patient safety for treatment. Most older people receive treatment in a nursing home (N.H.), rehabilitation, and homes. Based on the patient's disease, the infection is more. Most older adults are prone to this infection quickly; worse, the situation is due to a lack of immunity in their bodies. These increases in infections also increase mortality. This worse situation and deaths due to infection spread can be controlled by using infection control products in these places, which drives the market forward. In addition, infection control and prevention are significant parts of some chronic diseases, such as cancer and heart-related surgeries. By considering all these factors, the market has the highest market share. Growing adoption of a healthy lifestyle, increasing awareness around infection control, innovation of new products, growing healthcare expenditure, and increasing research and development in these sectors are boosting the U.S. infection control market.

Canada is another location for the infection control market in North America. According to a recent survey in Canada, nearly 15 percent of diseased people are died due to an increase in the infection spread in their body through the equipment or the surrounding. As a result, the Canadian Patient Safety Institute and the Public Health Agency of Canada are partnered to keep strict infection prevention and control rules in hospitals and clinics.

KEY MARKET PLAYERS

3M, Medtronic, STERIS plc., Olympus Corporation, and Belimed are some of the promising companies in the U.S. infection control market.